Abstract
Long-term travellers and expatriates are often non-compliant with malaria chemoprophylaxis due to a gradual neglect of the malaria risk combined with an unwillingness to take drugs for prolonged periods. The available regimes either have limited efficacy or are hampered by side effects, fears, cost and lack of data on long-term use. In order to prevent the dire consequences of malaria, we suggest tailoring the antimalarial strategy to the individual traveller. This requires balancing the risk of getting malaria, based on local transmission patterns, mosquito control and other factors, with the traveller's access to medical care and the options for chemoprophylaxis, the use of which in some cases may be limited to the rainy season or periods of travel to high-risk areas.
Bidragets oversatte titel | Malaria prophylaxis for long-term travellers and expatriates |
---|---|
Originalsprog | Dansk |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 167 |
Udgave nummer | 42 |
Sider (fra-til) | 3988-92 |
Antal sider | 5 |
ISSN | 0041-5782 |
Status | Udgivet - 17 okt. 2005 |
Emneord
- Antimalarials/administration & dosage
- Atovaquone
- Chloroquine/administration & dosage
- Counseling
- Doxycycline/administration & dosage
- Drug Combinations
- Humans
- Insect Bites and Stings/prevention & control
- Malaria/prevention & control
- Mefloquine/administration & dosage
- Mosquito Control
- Naphthoquinones/administration & dosage
- Proguanil/administration & dosage
- Risk Assessment
- Risk Factors
- Travel